The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,617,532 in first-year total cost, median $893,486.
Most frequent study sections
- Special Emphasis Panel[ZHL1 CSR-C (M1)]3
Most frequent institutions
- BETH ISRAEL DEACONESS MEDICAL CENTER1
- CINCINNATI CHILDRENS HOSP MED CTR1
- CLEVELAND CLINIC LERNER COM-CWRU1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Novel approaches to improve prediction of cancer-associated thrombosis1U01HL143402-01 | KHORANA, ALOK AMCCRAE, KEITH R. | CLEVELAND CLINIC LERNER COM-CWRU, OH | $905,594 | ZHL1 |
| 2018 | Biomarkers and mechanisms in cancer associated thrombosis1U01HL143365-01 | CHAIKOF, ELLIOTFLAUMENHAFT, ROBERT CZWICKER, JEFFREY | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $893,486 | ZHL1 |
| 2018 | Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis1U01HL143403-01 | FISHEL, MELISSA L.FLICK, MATTHEW J.HAN, BUMSOOWOLBERG, ALISA S. | CINCINNATI CHILDRENS HOSP MED CTR, OH | $818,452 | ZHL1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.